Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia

NCT00064649 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00064649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00064649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2004
Completion date
June 30, 2006
Enrollment
49 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia